Cargando…

High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease

BACKGROUND: Recent reports have identified distinct genomic patterns in ovarian carcinoma, including proliferative and mesenchymal-like groups, with worse outcome. The exact mechanisms driving the onset and progression of these tumors are still poorly understood. Additionally, researchers are concer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heredia-Soto, Victoria, Redondo, Andrés, Berjón, Alberto, Miguel-Martín, María, Díaz, Esther, Crespo, Roberto, Hernández, Alicia, Yébenes, Laura, Gallego, Alejandro, Feliu, Jaime, Hardisson, David, Mendiola, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955171/ https://www.ncbi.nlm.nih.gov/pubmed/29774110 http://dx.doi.org/10.18632/oncotarget.25098

Ejemplares similares

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models
por: Heredia-Soto, Victoria, et al.
Publicado: (2022)

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
por: Peláez-García, Alberto, et al.
Publicado: (2017)

Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2019)

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2021)

Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
por: Ramon-Patino, Jorge Luis, et al.
Publicado: (2022)

Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?
por: Escudero, Javier, et al.
Publicado: (2021)

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer
por: Mendiola, Marta, et al.
Publicado: (2023)

The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
por: Fernández, Lara P., et al.
Publicado: (2018)

Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling
por: López-Janeiro, Álvaro, et al.
Publicado: (2021)

The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
por: Heredia-Soto, V., et al.
Publicado: (2020)

Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel
por: Mendiola, Marta, et al.
Publicado: (2016)

Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
por: Martinez, Alejandra, et al.
Publicado: (2020)

Mouse models of epithelial ovarian cancer for preclinical studies
por: Karakashev, Sergey, et al.
Publicado: (2021)

Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
por: Heredia-Soto, Victoria, et al.
Publicado: (2021)

Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2022)

G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis
por: Nogués, Laura, et al.
Publicado: (2016)

Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
por: Redondo, Andrés, et al.
Publicado: (2014)

The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study
por: Martí, Covadonga, et al.
Publicado: (2022)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients
por: Gayarre, Javier, et al.
Publicado: (2016)

Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
por: Jungen, Samuel H., et al.
Publicado: (2023)

Angiogenesis-Related Gene Expression Profile with Independent Prognostic Value in Advanced Ovarian Carcinoma
por: Mendiola, Marta, et al.
Publicado: (2008)

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2013)

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer
por: Capellero, S., et al.
Publicado: (2020)

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
por: Dumont, Sander, et al.
Publicado: (2019)

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
por: Vinci, Maria, et al.
Publicado: (2012)

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2020)

Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
por: Ciucci, Alessandra, et al.
Publicado: (2022)

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer
por: Chen, Jiayu, et al.
Publicado: (2021)

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer
por: Sánchez-Navarro, Iker, et al.
Publicado: (2010)

Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features
por: Spagnolo, Emanuela, et al.
Publicado: (2023)

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
por: Pizarro, David, et al.
Publicado: (2023)

Unraveling Protein Interactions between the Temperate Virus Bam35 and Its Bacillus Host Using an Integrative Yeast Two Hybrid–High Throughput Sequencing Approach
por: Lechuga, Ana, et al.
Publicado: (2021)

Harnessing preclinical models for the interrogation of ovarian cancer
por: Qin, Tianyu, et al.
Publicado: (2022)

The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma
por: Heredia-Soto, Victoria, et al.
Publicado: (2023)

In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression
por: Montero-Calle, Ana, et al.
Publicado: (2023)

Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer
por: Espinosa, Enrique, et al.
Publicado: (2009)

High-throughput high-volume nuclear imaging for preclinical in vivo compound screening(§)
por: Macholl, Sven, et al.
Publicado: (2017)

Preclinical humanized mouse model with ectopic ovarian tissues
por: FU, SHILONG, et al.
Publicado: (2014)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hajci8ounfve6ofpbs6rnsaeab